You can learn a lot about the state of your health by the color of your urine. Medical professionals explain what cloudy urine might be indicating.
More than 1 in 7 adults are estimated to have chronic kidney disease, which is a progressive decrease in kidney function. As many as 9 in 10 of them don’t know they have it.
The US FDA has granted accelerated approval to atrasentan (Vanrafia) for reducing proteinuria in adults with primary ...
Clinicians should not neglect proteinuria testing in adults younger than age 40 years to identify those at high risk for sudden cardiac arrest.
Novartis’ Vanrafia (atrasentan) has been granted accelerated approval by the US Food and Drug Administration (FDA) to treat ...
The following is a summary of “Combination of urinary biomarkers can predict cardiac surgery-associated acute kidney injury: a systematic review and meta-analysis,” published in the March 2025 issue ...
The FDA has granted accelerated approval to Vanrafia to reduce proteinuria in adults with primary IgAN at risk of rapid disease progression.
Astrasentan becomes the first and only endothelin A receptor antagonist to focus on proteinuria reduction in primary ...
In an interview with HT Lifestyle, Dr Abhishek Agrawal, Consultant urologist, Jupiter Hospital Thane explained why t turns ...
Vanrafia, 2nd drug in Novartis' IgAN troika, crosses FDA finish line in payday for Chinook investors
When Novartis bought kidney disease biotech Chinook Therapeutics in 2023 for $3.2 billion upfront, the deal included a ...
Novartis ( NYSE: NVS) said on Thursday that it received US FDA's accelerated approval for Vanrafia as a treatment for adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback